+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Integra LifeSciences Holdings Corp (Integra) is a medical technology company that develops and manufactures engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for the measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors worldwide. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp Key Recent Developments

  • May 11, 2022: Hilco Redevelopment partners announces Integra to occupy new Braintree facility
  • Apr 27, 2022: Integra LifeSciences Reports First Quarter 2022 Financial Results
  • Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase
  • Nov 02, 2021: Integra LifeSciences Reports Third Quarter 2021 Financial Results
  • Oct 28, 2021: Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer

Key benefits of buying this profile include:

  • You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Integra LifeSciences Holdings Corp - Key Facts
  • Integra LifeSciences Holdings Corp - Key Employees
  • Integra LifeSciences Holdings Corp - Key Employee Biographies
  • Integra LifeSciences Holdings Corp - Major Products and Services
  • Integra LifeSciences Holdings Corp - History
  • Integra LifeSciences Holdings Corp - Company Statement
  • Integra LifeSciences Holdings Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Integra LifeSciences Holdings Corp - Business Description
  • Business Segment: Codman Specialty Surgical
  • Overview
  • Performance
  • Business Segment: Tissue Technologies
  • Overview
  • Performance
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Rest of World
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Integra LifeSciences Holdings Corp - Corporate Strategy
  • Integra LifeSciences Holdings Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Integra LifeSciences Holdings Corp - Strengths
  • Integra LifeSciences Holdings Corp - Weaknesses
  • Integra LifeSciences Holdings Corp - Opportunities
  • Integra LifeSciences Holdings Corp - Threats
  • Integra LifeSciences Holdings Corp - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Integra LifeSciences Holdings Corp, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • May 11, 2022: Hilco Redevelopment partners announces Integra to occupy new Braintree facility
  • Apr 27, 2022: Integra LifeSciences Reports First Quarter 2022 Financial Results
  • Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase
  • Nov 02, 2021: Integra LifeSciences Reports Third Quarter 2021 Financial Results
  • Oct 28, 2021: Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer
  • Sep 02, 2021: Integra LifeSciences Announces Participation In Upcoming Investor Conferences
  • Jul 28, 2021: Integra LifeSciences Reports Second Quarter 2021 Financial Results
  • Jun 24, 2021: Integra LifeSciences announces CEO succession plan
  • May 20, 2021: Integra LifeSciences Hosts Virtual Investor Day
  • May 07, 2021: Integra LifeSciences To Host Virtual Investor Day On May 20, 2021

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer

List of Tables
  • Integra LifeSciences Holdings Corp, Key Facts
  • Integra LifeSciences Holdings Corp, Key Employees
  • Integra LifeSciences Holdings Corp, Key Employee Biographies
  • Integra LifeSciences Holdings Corp, Major Products and Services
  • Integra LifeSciences Holdings Corp, History
  • Integra LifeSciences Holdings Corp, Other Locations
  • Integra LifeSciences Holdings Corp, Subsidiaries
  • Integra LifeSciences Holdings Corp, Key Competitors
  • Integra LifeSciences Holdings Corp, Ratios based on current share price
  • Integra LifeSciences Holdings Corp, Annual Ratios
  • Integra LifeSciences Holdings Corp, Interim Ratios
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Integra LifeSciences Holdings Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Integra LifeSciences Holdings Corp, Performance Chart (2017 - 2021)
  • Integra LifeSciences Holdings Corp, Ratio Charts
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2016 to YTD 2022

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Stryker Corp
  • Smith & Nephew Plc
  • Nexstim Plc
  • MiMedx Group Inc
  • LifeCell Corp
  • Becton Dickinson and Co